Resources to advance pediatrics and HIV prevention
Active Awarded Last action
- Contract number
- 75N93023D00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 11 $17,454,930 obligated
Award facts
- Opportunity
-
- Resources to advance pediatrics and HIV prevention science Pre-Solicitation · 75N93021R00020 · Posted Feb 18, 2022
- Combined order value
-
- $17,454,930 Current, with exercised options
- $34,119,255 Potential, with all options
- Last date to order 50% complete
- IDV ceiling 18% used
- $98,878,757.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Advanced Bioscience Laboratories, Inc. on April 15, 2023, with a $98,878,757 ceiling and ultimate completion date of April 14, 2030. This is a multiple-award IDIQ with no set-aside designation.
Place of performance is Rockville, Maryland. The IDIQ was established to procure preclinical development support services for HIV, pediatric, and prevention science products, including preclinical gap filling, animal model studies, bioanalytical support, product manufacturing, quality assurance and control, and scientific/quality support services.
Recent task-order activity under this IDIQ includes: a $6,169,389 delivery order for Quality Assurance/Quality Control support (awarded April 15, 2023, completing April 14, 2030); a $4,145,731 delivery order for expertise in development of pediatric drug formulations (awarded September 1, 2023, completing August 31, 2030); a $6,095,159 delivery order for professional pharmaceutical project management (awarded July 1, 2024, completing June 30, 2030); a $483,682 delivery order for material and data receipt, storage, shipping, and inventory services (awarded July 15, 2023, completing July 14, 2030); a $3,802,507 delivery order for bitter taste receptor blockers to improve pediatric medicine palatability—blocker discovery (awarded July 1, 2024, completing September 29, 2027); a $2,413,956 delivery order for bitter taste receptor blockers with trained human sensory panel support (awarded July 1, 2024, completing September 29, 2027); a $253,411 delivery order for participation in a workshop on animal models supporting pediatric formulation development (awarded July 1, 2024, completing June 30, 2025); a $4,328,663 delivery order for expertise in the product development lifecycle (awarded September 1, 2024, completing August 31, 2030); a $1,193,090 delivery order for AI/machine learning enhancement of the STEP pediatric excipient database (awarded August 1, 2024, completing September 30, 2025); and a $2,674,036 delivery order for scalable, reliable AI/machine learning-driven integration and interrogation to modernize the STEP pediatric excipient database (awarded August 1, 2026, completing July 31, 2027). All delivery orders are cost-plus-fixed-fee and carry no set-aside designation.
Task orders
Show all 11
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93023D00001?
75N93023D00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2023.
How much is contract 75N93023D00001 worth?
Orders under 75N93023D00001 have obligated $17,454,930. Their combined potential value, with all options, is $34,119,255. 75N93023D00001's own ceiling is $98,878,757.
How many orders have been placed under contract 75N93023D00001?
11 orders have been placed under 75N93023D00001, the latest on September 30, 2026.
Who can order from contract 75N93023D00001?
75N93023D00001 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93023D00001 part of a contract vehicle?
Yes. 75N93023D00001 is part of Resources to Advance Pediatrics and HIV Prevention Science.
Was contract 75N93023D00001 competed?
The extent of competition for 75N93023D00001 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV